NCT06149936

Brief Summary

This study aimed to evaluate the efficacy and safety of the 308-nm excimer lamp in resistant AA treated with topical minoxidil .

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Dec 2023

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 8, 2021

Completed
2.1 years until next milestone

First Posted

Study publicly available on registry

November 29, 2023

Completed
2 days until next milestone

Study Start

First participant enrolled

December 1, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2024

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

November 29, 2023

Status Verified

November 1, 2023

Enrollment Period

1 year

First QC Date

October 8, 2021

Last Update Submit

November 27, 2023

Conditions

Alopecia Areata

Keywords

excimer light

Outcome Measures

Primary Outcomes (1)

  • alopecia areata with ecimer light

    evulate patients monthly during treatment with excimer light and minoxidil gel for three months With 20 patients who should completely recovered from alopecia areata.

    3 months

Interventions

excimer lightDEVICE

Excimer laser using high-dose monochromatic UV radiation

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Age GroupsAdult (18-64)
Sampling MethodProbability Sample
Study Population

patients take 24 sessions with excimer light for 3 months

You may qualify if:

  • ● Having multiple patches of AA.
  • Duration of alopecia \>1 year
  • No topical or systemic treatment for the last 4 months
  • Agreement to regular visits for treatment and follow-up.

You may not qualify if:

  • ● A single form of AA.
  • Alopecia for \<1 year.
  • Being on other modalities of treatment.
  • Treatment within the last 4 months.
  • Photosensitive disorders.
  • Pregnancy or breastfeeding.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Alopecia Areata

Condition Hierarchy (Ancestors)

AlopeciaHypotrichosisHair DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Central Study Contacts

hagar maher, master

CONTACT

01117480774hagar_maher@hotmail.com

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
3 Months
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
doctor

Study Record Dates

First Submitted

October 8, 2021

First Posted

November 29, 2023

Study Start

December 1, 2023

Primary Completion

November 30, 2024

Study Completion

December 30, 2024

Last Updated

November 29, 2023

Record last verified: 2023-11